BG00012 Standard Formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG00012 Standard Formulation, covering 2010-02-17 to 2010-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient [Phase 1]